Upcoming Annual Meeting
Christopher Etherton-Beer is a Geriatrician and Clinical Pharmacologist, a Professor in the Medical School at the University of Western Australia, and a Medical Co-Director at Royal Perth Bentley Group. He Chairs the WA Therapeutic Advisory Group and is a member of the Pharmaceutical Benefits Advisory Committee. CEB’s research interests are focused on pharmacogeriatrics, stroke medicine, the care of frail older people, residential care services and medical education.
Janice Schwartz, MD, FACC, ASGF, FAHA, FACC is Professor of Medicine at the University of California, San Francisco. She is a board-certified internist, cardiologist and a geriatrician with significant experience in clinical pharmacology. She has been investigating the changes with aging that determine responses to therapeutic medications and ways to optimize medication use in older adults since the mid 1980’s—at UCSF, Baylor, Northwestern, and the Jewish Home of SF. Her research has involved basic laboratory research, clinical trials and population research and she is the author of over 200 publications including scientific articles, reviews, and book chapters. She has been named one of the Best Doctors in the U.S. (geriatric medicine), received the 2012 William B Abrams Award in Geriatric Clinical Pharmacology from the American Society of Clinical Pharmacology and Therapeutics, and the 2019 Award for Excellence in Clinical Pharmacology from PhRMA, Foundation, Inc. Recently she was an ORISE Visiting Professor in the Office of Clinical Pharmacology at the FDA from October 2019-November 2020 with the major goal of advocating for improving evaluation of drugs older adults. One product was the recent March, 2021 FDA Workshop entitled “Roadmap to 2030 for Drug Evaluation in Older Adults” that she Co-Chaired.
ADeN 2021 Annual Meeting Virtual Poster Gallery
The posters presented here were submitted via a call for abstracts for rapid fire presentations. We were overwhelmed with fantastic submissions but unfortunately did not have enough time to offer them all oral presentations.
The posters presented here have not been peer-reviewed, with the rights and responsibilities remaining with the authors (not ADeN).
Marea O’Donnell “Deprescribing – Bridging Value to Aged Care”
Abstract submission for rapid fire presentations
We are pleased to announce submissions are now open for the ADeN 2021 Virtual Meeting rapid fire presentations. We particularly encourage clinicians, PhD candidates and early career researchers to submit abstracts. This year’s meeting will be hosted as two sessions – morning and evening – with rapid fire presentations to take place in the morning session (final program is subject to changes). As this is a shorter meeting, presenters will not have time for questions, however, your contact details can be circulated to conference delegates if you wish.
If we receive more submissions than available time, students and ECRs will be given preference, as will submissions that are clear and relevant to deprescribing in Australia.
- Presentations will be 3-5 minutes (no Q&A to follow).
- Submission is due COB 29th October 2021.
- Acceptance of abstracts will be judged by members of the ADeN virtual meeting committee
- Presenters notified of the outcome by e-mail by COB 1st November 2021.
To be considered for a rapid fire presentation, please complete this template and submit this form as a word document to A.Page@alfred.org.au by COB 29th October 2021. If you have any questions, please email Amy Page.